HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $222,000 | -98.9% | 3,591 | -98.6% | 0.00% | -100.0% |
| Q2 2022 | $20,667,000 | -43.8% | 259,116 | -25.9% | 0.04% | -22.4% |
| Q1 2022 | $36,780,000 | +0.8% | 349,586 | +3.3% | 0.05% | +11.4% |
| Q4 2021 | $36,480,000 | -2.6% | 338,532 | -1.0% | 0.04% | -4.3% |
| Q3 2021 | $37,459,000 | +20.4% | 341,965 | +2.9% | 0.05% | +21.1% |
| Q2 2021 | $31,111,000 | +5.7% | 332,235 | +3.9% | 0.04% | 0.0% |
| Q1 2021 | $29,428,000 | +19.1% | 319,727 | -5.4% | 0.04% | +15.2% |
| Q4 2020 | $24,717,000 | -6.3% | 337,895 | -0.5% | 0.03% | -13.2% |
| Q3 2020 | $26,384,000 | -3.4% | 339,647 | -30.9% | 0.04% | -13.6% |
| Q2 2020 | $27,320,000 | -34.3% | 491,551 | -65.0% | 0.04% | -48.8% |
| Q1 2020 | $41,595,000 | -18.1% | 1,404,280 | +0.1% | 0.09% | 0.0% |
| Q4 2019 | $50,804,000 | +29.5% | 1,403,428 | -2.6% | 0.09% | +13.2% |
| Q3 2019 | $39,242,000 | +37.6% | 1,441,162 | +21.5% | 0.08% | +43.4% |
| Q2 2019 | $28,528,000 | – | 1,185,701 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |